Combination Chemotherapy With CS-1008 to Treat Ovarian Cancer
Status:
Completed
Trial end date:
2011-08-23
Target enrollment:
Participant gender:
Summary
This trial assessed the effect of treatment with CS-1008 in combination with
paclitaxel/carboplatin on response in patients with locally advanced or metastatic ovarian
cancer.